Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating nucleic acids as a tumor marker.

K C A Chan1, Y M D Lo

  • 1Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong Special Administrative Region.

Histology and Histopathology
|August 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? - Considerations on pre-analytical aspects by the IFCC workgroup cfDNA.

Clinica chimica acta; international journal of clinical chemistry·2021
Same author

Quantitative T1ρ MRI of the Head and Neck Discriminates Carcinoma and Benign Hyperplasia in the Nasopharynx.

AJNR. American journal of neuroradiology·2020
Same author

MRI of benign hyperplasia in the nasopharynx: is there an association with Epstein-Barr virus?

Clinical radiology·2020
Same author

Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma.

AJNR. American journal of neuroradiology·2020
Same journal

Morphological, molecular, and electrophysiological aspects of skeletal muscle satellite cell-niche interactions: Focus on interstitial stromal non-myogenic cells.

Histology and histopathology·2026
Same journal

Age-related morphological and histological changes in the dromedary camel thymus.

Histology and histopathology·2026
Same journal

Isofraxidin ameliorates CCl<sub>4</sub>-induced liver fibrosis in mice by inhibiting the NF-κB pathway.

Histology and histopathology·2026
Same journal

FOXO3/HMOX1 axis promotes melanoma progression by regulating ferroptosis and immune escape.

Histology and histopathology·2026
Same journal

Immunohistochemical evaluation of CD44 expression and its correlation with clinicopathological factors and molecular markers (EGFR, STAT3, and lipid metabolism-related proteins) in oral squamous cell carcinoma.

Histology and histopathology·2026
Same journal

Betulinic acid mitigates septic cardiomyopathy in mice through modulating the TLR4/MyD88/NF-κB signaling axis and NLRP3 inflammasome pathway.

Histology and histopathology·2026
See all related articles

Circulating cell-free nucleic acids, including tumor-derived and viral types, are elevated in cancer patients. Their levels correlate with disease burden, offering potential for cancer screening and monitoring.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Malignant diseases are associated with elevated levels of cell-free nucleic acids (cfNAs) in circulation.
  • Tumor-specific genetic and epigenetic alterations can be detected in circulating cfNAs.
  • Increased circulating viral nucleic acids are observed in virus-associated cancers.

Purpose of the Study:

  • To review methods for detecting tumor-related nucleic acids in circulation.
  • To discuss the potential of circulating nucleic acids as biomarkers for cancer.
  • To explore their utility in screening, monitoring, and prognostication of malignant diseases.

Main Methods:

  • Review of literature on detection techniques for circulating nucleic acids.
  • Analysis of studies reporting cfNAs in plasma and serum of cancer patients.

Related Experiment Videos

  • Evaluation of the correlation between cfNA levels, tumor load, and disease extent.

    • Main Results:

    • Tumor-derived and viral nucleic acids are consistently found in the circulation of cancer patients.
    • Concentrations of these nucleic acids generally correlate with tumor burden and disease stage.
    • Serial monitoring of plasma nucleic acids shows promise for tracking disease progression.

    Conclusions:

    • Circulating nucleic acids represent promising biomarkers for cancer detection and management.
    • Detection methods and their clinical applications in screening, monitoring, and prognostication are discussed.
    • Further research into cfNA analysis can enhance cancer care strategies.